RT Book, Section
A1 Rogers, Vanessa L.
A1 Roberts, Scott W.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1184182296
T1 Varicella in Pregnancy
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1184182296
RD 2024/04/18
AB Commonly  known  as  chickenpox,  varicella-zoster  virus  (VZV)  infection  has  a  fairly  benign  course  when  incurred  during  childhood  but  may  result  in  serious  illness  in  adults,  particularly  during  pregnancy.  Infection  results  in  lifelong  immunity.  Approximately  95%  of  women  born  in  the  United  States  have  VZV  antibodies  by  the  time  they  reach  reproductive  age.  The  incidence  of  VZV  infection  during  pregnancy  has  been  reported  as  up  to  7:10,000.  The  vaccine  is  contraindicated  in  pregnancy  because  the  effects  of  the  vaccine  on  the  fetus  are  unknown.  Nonpregnant  women  who  are  vaccinated  should  avoid  pregnancy  for  1  month  after  injection.  Inadvertent  vaccination  in  early  pregnancy  or  within  a  month  of  pregnancy  is  not  an  indication  for  termination,  although  women  should  be  counseled  about  theoretical  risks.